Patient & Visitor Alert: Because flu cases are on the rise, starting February 24, children 12 and younger
will be restricted from visiting hospitals and certain inpatient facilities throughout Carolinas HealthCare System. Learn more.


Carolinas HealthCare System

Research and Clinical Trials

Title  
CARE (Combating Antibiotic Resistance Enterobacteriaceae
Brief Description  
Patients with positive cultures for CRE (Cabapenem-Resistant Enterobacteriaceae) will be treated with either plazomicin or colistin (both with added meropenem or tigecycline) for up to 4 days. The study is looking to see if plazomicin is as good or better than the current treatment for CRE.
Who may be Eligible  
Ages 18-15; Positive culture for CRE; Not pregnant or breast feeding; Not have study defined prohibited co-infections; Not have antibiotic therapy for more than 72 hours prior to start; Not be on study disallowed mdications.
Start Date  
11/01/2015
IRB Number  
10-15-15B
Principal Investigator  
Horton, James
Contact Name  
Jessica

For More Information, Contact   Jessica  A.  Kearney-Bryan , BSN
Phone:  (704) 355-0244  Fax:  (704) 446-7641 
Email:  Jessica.Kearney-bryan@carolinashealthcare.org
Address:  1350 South Kings Drive
3rd Floor ID Clinic
Charlotte, NC 28207
Close